3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Phase 2
1
Status
Recruiting
1
Completed
1
Sponsor Class
OTHER
2
NIH
1
NETWORK
1
Study Type
Interventional
2
Sponsor
Cancer Type
Lymphoid
2
Conditions
Hodgkin Disease
41
Lymphoma
16
Urinary Bladder Neoplasms
7
Melanoma
6
Prostatic Neoplasms
3
Neoplasms
3
Leukemia
3
Glioma
3
Carcinoma, Non-Small-Cell Lung
3
Testicular Neoplasms
2
Testicular Germ Cell Tumor
2
Skin Neoplasms
2
Lymphoma, Large-Cell, Anaplastic
2
Central Nervous System Neoplasms
2
Breast Neoplasms
2
Brain Neoplasms
2
Astrocytoma
2
Urothelial Carcinoma of the Bladder
1
Urethral Neoplasms
1
Ureteral Neoplasms
1
Teratoma
1
Survival Without Progression
1
Seminoma
1
Rhabdoid Tumor
1
Recurrence
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Precancerous Conditions
1
Pathologic Complete Response
1
Oligodendroglioma
1
Neurofibromatosis 1
1
Interventions
Cyclophosphamide
48
fludarabine phosphate
32
Peripheral Blood Stem Cell Transplantation
32
Whole-Body Irradiation
26
Etoposide
23
Mycophenolic Acid
22
Rituximab
20
Filgrastim
18
Doxorubicin
18
Vincristine
16
Cyclosporine
16
Busulfan
16
Tacrolimus
15
Prednisone
15
Methotrexate
13
Melphalan
13
Antilymphocyte Serum
12
Cytarabine
11
Radiotherapy
10
Carboplatin
10
Bortezomib
9
romidepsin
8
Ifosfamide
8
Cord Blood Stem Cell Transplantation
8
Methylprednisolone
7
Lenalidomide
7
Flow Cytometry
7
Brentuximab Vedotin
7
Sirolimus
6
Everolimus
6
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
OTHER
×
Lymphoma, Large-Cell, Anaplastic
×
Vinblastine
×
Clear all
NCT07013565
2026-05-20
ACCELERATE
New York Medical College
Phase 2
Recruiting
20 enrolled
NCT00006455
2022-05-31
ALCL 99
Gustave Roussy, Cancer Campus, Grand Paris
Phase 3
Completed
885 enrolled